Reclast Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic Acid
Condition:   Postmenopausal Osteoporosis Interventions:   Drug: Zoledronic Acid Injection;   Drug: Placebo Sponsor:   Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Pravastatin Reduces Acute Phase Response of Zoledronic Acid
Condition:   Postmenopausal Osteoporosis Interventions:   Drug: Pravastatin Sodium 80 MG;   Drug: Placebo Sponsor:   Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic Acid
Condition:   Postmenopausal Osteoporosis Interventions:   Drug: Zoledronic Acid Injection;   Drug: Placebo Sponsor:   Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Pravastatin Reduces Acute Phase Response of Zoledronic Acid
Condition:   Postmenopausal Osteoporosis Interventions:   Drug: Pravastatin Sodium 80 MG;   Drug: Placebo Sponsor:   Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic Acid
Condition:   Postmenopausal Osteoporosis Interventions:   Drug: Zoledronic Acid Injection;   Drug: Placebo Sponsor:   Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Pravastatin Reduces Acute Phase Response of Zoledronic Acid
Condition:   Postmenopausal Osteoporosis Interventions:   Drug: Pravastatin Sodium 80 MG;   Drug: Placebo Sponsor:   Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic Acid
Condition:   Postmenopausal Osteoporosis Interventions:   Drug: Zoledronic Acid Injection;   Drug: Placebo Sponsor:   Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Pravastatin Reduces Acute Phase Response of Zoledronic Acid
Condition:   Postmenopausal Osteoporosis Interventions:   Drug: Pravastatin Sodium 80 MG;   Drug: Placebo Sponsor:   Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic Acid
Condition:   Postmenopausal Osteoporosis Interventions:   Drug: Zoledronic Acid Injection;   Drug: Placebo Sponsor:   Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Pravastatin Reduces Acute Phase Response of Zoledronic Acid
Condition:   Postmenopausal Osteoporosis Interventions:   Drug: Pravastatin Sodium 80 MG;   Drug: Placebo Sponsor:   Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic Acid
Condition:   Postmenopausal Osteoporosis Interventions:   Drug: Zoledronic Acid Injection;   Drug: Placebo Sponsor:   Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Pravastatin Reduces Acute Phase Response of Zoledronic Acid
Condition:   Postmenopausal Osteoporosis Interventions:   Drug: Pravastatin Sodium 80 MG;   Drug: Placebo Sponsor:   Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials